Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Age and Sex Adjusted Prevalence and Annual Incidence of Multiple Sclerosis in East-Azerbaijan, Iran Publisher Pubmed



Talebi M1, 3 ; Sadigheteghad S1, 3 ; Sahraian MA2 ; Fahidi A1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Sina MS Research Center, Sina Hospital, and Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Multiple Sclerosis and Related Disorders Published:2021


Abstract

Background: Incidence and prevalence of multiple sclerosis (MS) is postulated to be rising in recent decades. Therefore, updating and completing the information of patients is essential, especially in high population areas. East-Azerbaijan is the largest and most populous province in the northwest of Iran. This study aimed to determine the prevalence and annual incidence of MS from 2008 to 2017 in East-Azerbaijan. Methods: We evaluated the data of all patients who had registered at the MS center in the university hospital. The data include nearly all MS patients in the East-Azerbaijan region, because it is the only referral site in the area. All of the reported rates were calculated in 100,000 of the total population. Results: By the end of 2017, the number of MS patients was 2995 (residing in the, with 769 (25.67%) men and 2226 (74.32%) women. The prevalence rate was 75.72/100,000 (95 % CI: 73.06-78.48), 38.2 in men (95% CI: 35.5-41.0), and 114.61 for women (95% CI: 109.9-119.4), with a female to male (F/M) ratio of 3:1. The mean annual incidence rate was 7.63/100,000 (95% CI: 5.6-9.3), and this rate was higher in women than men. During the nine years, the incidence rate increased. The patients' mean age was 32.33 ± 8.92, with a peak prevalence in 25-29 years for both genders. In this study, 13.9% of patients had a positive MS family history. Conclusions: This study showed a high prevalence of MS in the region. There is a significant increase in the incidence of MS during the nine years in East-Azerbaijan. The increment of incidence was more prominent in women. Also, considering the increasing incidence rate, it is concluded that the risk of MS is increasing in this region. © 2021 Elsevier B.V.
Other Related Docs
9. Prevalence and Incidence of Multiple Sclerosis in Ardabil, Northwest of Iran, Multiple Sclerosis and Related Disorders (2021)
19. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran, Iranian Journal of Public Health (2017)
23. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
31. A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021, Journal of Mazandaran University of Medical Sciences (2022)
33. Registry-Based Incidence of Multiple Sclerosis in Southwestern Iran, 2001-2014, Bangladesh Medical Research Council Bulletin (2016)
35. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
39. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
47. Quality of Life and Cognitive Emotion Regulation Strategies in Multiple Sclerosis Patients, Journal of Rational - Emotive and Cognitive - Behavior Therapy (2023)
48. Clinical and Imaging Features of Familial and Sporadic Multiple Sclerosis, Caspian Journal of Neurological Sciences (2025)
50. Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients From Iran, Iranian Journal of Pharmaceutical Research (2016)